Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 08, 2021

SELL
$56.65 - $64.55 $197,028 - $224,504
-3,478 Closed
0 $0
Q2 2020

Jul 23, 2020

SELL
$72.34 - $84.0 $36,170 - $42,000
-500 Reduced 12.57%
3,478 $268,000
Q2 2019

Jul 26, 2019

SELL
$61.87 - $69.38 $30,935 - $34,690
-500 Reduced 11.17%
3,978 $269,000
Q4 2018

Jan 23, 2019

SELL
$60.54 - $79.0 $12,108 - $15,800
-200 Reduced 4.28%
4,478 $280,000
Q3 2018

Oct 23, 2018

SELL
$71.28 - $78.92 $242,352 - $268,328
-3,400 Reduced 42.09%
4,678 $361,000
Q2 2018

Jul 31, 2018

SELL
$64.88 - $75.68 $188,152 - $219,472
-2,900 Reduced 26.42%
8,078 $572,000
Q1 2018

May 04, 2018

BUY
$72.84 - $88.8 $546,300 - $666,000
7,500 Added 215.64%
10,978 $828,000
Q3 2017

Nov 01, 2017

BUY
$72.11 - $85.47 $250,798 - $297,264
3,478
3,478 $282,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Portland Global Advisors LLC Portfolio

Follow Portland Global Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Portland Global Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Portland Global Advisors LLC with notifications on news.